Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




HPV Test More Accurate than Pap for Cervical Cancer

By HospiMedica staff writers
Posted on 11 Jul 2001
A new study has found that testing for the human papillomavirus (HPV) with the Hybrid Capture 2 (hc2) test is more effective than the traditional Pap smear for the primary screening of cervical cancer. More...
The study was published in the June 2001 issue of the British Journal of Cancer.

The study, involving 7,932 women in France, revealed that the HPV hc2 test was 100% sensitive in detecting high-grade cervical lesions, compared to only 68.1% for a Pap smear. The study was conducted between August 1997 and February 2001 on women with a median age of 34 years. The Hybrid Capture hc2 test was developed by Digene Corp. (Gaithersburg, MD, USA; www.digene.com), which develops and markets DNA and RNA testing systems.

"This new data confirms earlier studies showing that the hc2 HPV test can detect virtually all high-grade cervical disease with good specificity,” said Dr. Attila Lorincz, chief scientific officer of Digene. "The study also adds to the ever-growing body of evidence from around the world that shows the effectiveness of HPV testing in the primary screening of cervical cancer.”




Related Links:
Digene

Gold Member
Neonatal Heel Incision Device
Tenderfoot
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Surgical System
Stealth AXiS
Fetal Monitor
BT-380
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.